← All news
Markets
H.C. Wainwright reiterates Dogwood Therapeutics stock rating at buy
Covered by 1 outlet
All coverage · 4 articles
Investing.com Canada
·Sep 3, 11:48 UTC
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy
Investing.com Canada
·Sep 3, 11:48 UTC
H.C. Wainwright reiterates Halozyme stock rating on deal momentum
Investing.com News
·Sep 3, 11:46 UTC
H.C. Wainwright reiterates Halozyme stock rating on deal momentum
Investing.com UK
·Sep 2, 11:58 UTC